Pentobarbital will decrease the level or effect of fentanyl transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with CYP3A4 inducers could lead to a decrease Per mezzo di fentanyl plasma concentrations, lack of efficacy or, possibly, development of a withdrawal syndrome Durante a patient who https://bookmarks-hit.com/story22745580/note-dettagliate-su-pentobarbital-natrium